Related Experiment Video
Updated: Jul 13, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Cardiac complications after stem cell transplantation
Tariq Mahmood Satti1, Khalil Ullah, Pervez Ahmed
1Department of Haematology, AFBMTC, Rawalpindi.
Abstract:
Cardiac insufficiency / toxicity has been recognized as a complication of intensive cytotoxic therapy used in stem cell transplant setting. The incidence of clinically significant cardiac toxicity following high dose chemotherapy ranges between 2 - 43% with mortality of 2 - 9%. Two patients are reported who developed life-threatening cardiac complications following cyclophosphamide and busulphan therapy requiring pericardiocentesis and pericardiectomy.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization II: Right Heart Catheterization
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

